STADA Supports Cancer Care in Uganda
STADA has donated 4,000 vials of the cancer medicine bortezomib to the Uganda Cancer Institute, in cooperation with the humanitarian organization Direct Relief. This donation will enable vital treatment for more than 1,000 patients.
Together for Better Access to Cancer Care
Bortezomib is a targeted treatment plays a key role in modern cancer therapy. However, it has until recently been largely out of reach for many patients in low- and middle-income countries. This initiative is a clear example of how we live our purpose and of our strong ESG commitment. It shows the impact we can make together – and it is recognized with great appreciation.
Interview with Dr. Clement Okello
In this exclusive interview, Dr. Clement Okello, consultant hematologist and clinical researcher at the Uganda Cancer Institute, explains how STADA’s donation of 4,000 bortezomib vials through the Direct Relief charity is transforming the lives of thousands of people living with cancer.
I appreciate the donation from STADA on behalf of countless patients the world over. These patients would not be able to afford this type of medicine without your support.
Dr. Clement Okello
